Safety and Feasibility Study of the Chartis System With Heterogeneous Emphysema Prior to Endobronchial Lung Volume Reduction (ELVR)
NCT ID: NCT00684892
Last Updated: 2009-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
25 participants
INTERVENTIONAL
2008-05-31
2008-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Free Flow Medical Lung Tensioning Device System for the Treatment of Severe Emphysema
NCT04520152
A Study Evaluating an Advanced Pneumatic Compression Device Versus Usual Care for Treatment of Head and Neck Lymphedema
NCT04797390
Bronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction
NCT01102712
Endoscopic Lung Volume Reduction After Catheter-based CV Measurement in Patients With Heterogeneous Emphysema and Complete Interlobar Fissures
NCT01902732
PEEP as Rescue Therapy for Asthmatics With Elevated BMI
NCT02696980
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Chartis System
Assessment of airway flow and pressure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chartis System
Assessment of airway flow and pressure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for clinically indicated ELVR procedure
Exclusion Criteria
* Active pulmonary infection
* Active asthma or lung hyper-responsiveness
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pulmonx Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pulmonx, Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Felix Herth, MD
Role: PRINCIPAL_INVESTIGATOR
Thoraxklinik am Universitatsklinikum Heidelberg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Thoraxklinik am Universitatsklinikum Heidelberg
Heidelberg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRT01029
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.